Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...

Karyopharm Therapeutics Inc.’s KPTI share price has surged by 5.06%, which has investors questioning if this is right time to ...

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs) ...

Nearly a quarter of patients with difficult-to-control type 2 diabetes have hypercortisolism, with even higher prevalence ...

Teddi Mellencamp reveals the physical and emotional challenges of brain surgery and stage 4 cancer Read ahead to know about ...

Nordic Pharma, a subsidiary of Nordic Group B.V., announced a partnership with Harrow, a leading North American eyecare ...

The Darzalex Faspro market report provides a comprehensive analysis of market size, growth potential, and segmentation, covering major regions and countries. Key factors driving growth include rising ...

Corticosteroid therapy must be tapered because of its interactions with the hypothalamic-pituitary-adrenocortical (HPA) axis. The hypothalamus secretes corticotropin releasing factor, which acts ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to ...